Skip to content

Understanding the Role of Hepatic Stellate Cells: What are vitamin A storing cells in the liver?

4 min read

The liver stores approximately 80% of the body's total vitamin A reserves. This critical function is performed by specialized liver cells, known as hepatic stellate cells, which are what are vitamin A storing cells in the liver. These remarkable cells manage the body's retinoid supply and undergo a dramatic transformation during liver injury.

Quick Summary

Hepatic stellate cells, or Ito cells, reside in the liver's perisinusoidal space, storing vitamin A as retinyl esters in lipid droplets. They regulate retinoid metabolism and play a key role in liver health, but their activation due to liver injury contributes to fibrosis.

Key Points

  • Identity: The primary vitamin A storing cells in the liver are known as hepatic stellate cells (HSCs).

  • Location: HSCs are found in the perisinusoidal space, also known as the space of Disse, located between liver hepatocytes and sinusoidal endothelial cells.

  • Storage Form: In their quiescent state, HSCs store vitamin A in cytoplasmic lipid droplets in the form of retinyl esters.

  • Activation and Fibrosis: In response to liver injury, HSCs become activated, lose their vitamin A reserves, and transform into myofibroblasts that produce scar tissue.

  • Other Functions: Beyond vitamin A storage, quiescent HSCs are involved in regulating the extracellular matrix, immune responses, and liver regeneration.

In This Article

What are vitamin A storing cells in the liver? A detailed overview

Within the complex architecture of the liver, a specific cell type, the hepatic stellate cell (HSC), is responsible for the body's vitamin A storage. These cells, also historically known as Ito cells, fat-storing cells, or lipocytes, are a type of pericyte located in a small area between the liver's sinusoids and hepatocytes, called the space of Disse. In their quiescent (inactive) state, they are star-shaped and contain multiple lipid droplets rich in vitamin A. This strategic location and unique storage capacity make HSCs central to both normal liver function and the development of liver disease when they become activated.

The Storage Mechanism of Vitamin A

The process of vitamin A storage by hepatic stellate cells is a multi-step journey. Dietary vitamin A, primarily in the form of retinyl esters, is absorbed in the small intestine and packaged into chylomicrons. These lipid particles are then transported to the liver, where they are taken up by hepatocytes. The hepatocytes hydrolyze the retinyl esters into retinol before transferring the retinol to the stellate cells.

In the HSCs, an enzyme called lecithin:retinol acyltransferase (LRAT) converts the retinol back into its storage form, retinyl ester, which is then accumulated in the cell's distinct lipid droplets. This continuous process allows the liver to act as a buffer, preventing vitamin A deficiency and regulating its availability to other body tissues. The capacity to store vitamin A is so efficient that the liver of a well-nourished person can hold enough reserves to last for several months.

Functions of Quiescent Hepatic Stellate Cells

In a healthy liver, HSCs are not merely passive storage depots. Their quiescent state involves a number of crucial functions that maintain liver homeostasis:

  • Regulating the Extracellular Matrix (ECM): HSCs produce and maintain the normal composition of the extracellular matrix in the space of Disse, providing structural support for other liver cells.
  • Immune Modulation: HSCs are involved in liver immunity by influencing the behavior of various immune cells, including natural killer cells and macrophages.
  • Production of Growth Factors: They produce factors like hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF), which are essential for normal liver development and regeneration after injury.
  • Modulating Sinusoidal Blood Flow: By extending processes that can contract around liver sinusoids, they help regulate the flow of blood through the liver, although this is more prominent in their activated state.

The Transformation from Quiescent to Activated

One of the most critical aspects of hepatic stellate cell biology is their ability to change dramatically in response to liver injury. This transformation, known as activation, marks a key event in the progression of chronic liver diseases such as fibrosis and cirrhosis. The activating signals can come from various sources of injury, including inflammation from viral hepatitis, alcohol consumption, and metabolic disorders.

Key features of HSC activation include:

  • Loss of the characteristic lipid droplets and their stored vitamin A.
  • Phenotypic change from a quiescent, star-shaped cell to a proliferative, contractile, myofibroblast-like cell.
  • Increased synthesis and secretion of a wide range of extracellular matrix components, most notably type I and type III collagen.
  • Increased motility (chemotaxis) and expression of inflammatory signaling molecules.
  • Reduced ability to revert to a resting state, especially if the injury is chronic.

Quiescent vs. Activated Hepatic Stellate Cells

Feature Quiescent HSC (Healthy Liver) Activated HSC (Liver Injury)
Primary Function Vitamin A storage; ECM homeostasis Excessive extracellular matrix (ECM) production
Vitamin A Content High; contained in lipid droplets as retinyl esters Low or absent; lipid droplets are lost
Morphology Star-shaped, with fat-filled cytoplasmic droplets Myofibroblast-like, contractile, with fewer or no lipid droplets
Proliferation Low or non-proliferative High, leading to an increased number of cells
Role in Fibrosis Prevents fibrosis through ECM regulation Drives fibrosis by producing scar tissue (collagen)
Associated Condition Healthy liver parenchyma Chronic liver diseases like cirrhosis

Conclusion

Hepatic stellate cells are the primary vitamin A storing cells in the liver, maintaining a critical store of this essential nutrient in their lipid droplets. Located in the space of Disse, they also contribute to the structural integrity and immune regulation of the healthy liver. However, upon liver injury, they transform into activated myofibroblasts, losing their vitamin A and becoming a primary driver of liver fibrosis. Understanding this duality is fundamental to appreciating the complex biology of the liver and the mechanisms behind chronic liver disease. The interplay between a quiescent, retinoid-rich HSC and an activated, fibrogenic one represents a key crossroads in liver health.

Potential therapeutic targets

The ability of HSCs to activate and drive fibrosis has made them a significant target for potential therapeutic interventions for chronic liver diseases. By focusing on ways to suppress HSC activation, promote their inactivation, or induce their apoptosis, researchers aim to halt or even reverse the progression of fibrosis. This involves targeting specific signaling pathways and factors, such as inflammatory cytokines and growth factors, that trigger the quiescent-to-activated transition.

For example, interventions have been explored to re-establish the normal matrix composition and reintroduce factors that promote HSC quiescence. The successful reversal of fibrosis in animal models, and in some human cases, demonstrates the potential for these targeted approaches. Continued research into the specific mechanisms that govern HSC behavior will be critical for developing effective therapies to combat widespread liver diseases. For further reading on the physiology and pathology of hepatic stellate cells, see this article Hepatic stellate cells in physiology and pathology.

Frequently Asked Questions

Hepatic stellate cells are also known by several other names, including Ito cells, fat-storing cells, perisinusoidal cells, and lipocytes.

These cells are located in the perisinusoidal space, or space of Disse, which is a small area found between the liver's sinusoidal blood vessels and the adjacent hepatocytes.

Vitamin A (retinol) is delivered to the liver, transferred from hepatocytes to the stellate cells, and then converted into its storage form, retinyl esters, within lipid droplets via the enzyme LRAT.

HSCs become activated due to various forms of liver injury, including inflammation, oxidative stress, and exposure to toxins. This activation transforms them into myofibroblasts.

Liver fibrosis is the excessive accumulation of scar tissue. Activated HSCs are the primary producers of this scar tissue, mainly collagen, which over time can lead to a more severe condition called cirrhosis.

Yes, if the source of the liver injury is removed or treated, some activated HSCs can undergo apoptosis (cell death) or revert to a more quiescent-like state, though they may remain primed for future activation.

While the liver contains the main storage site for vitamin A, similar stellate-type cells that store retinoids also exist in other organs, such as the pancreas, lung, and intestines.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.